Drug intelligence / Profile preview

Huashi Jiangzhuo

Development stage: Unknown
Lead developer: Guang'anmen Hospital
Administration: Oral

Overview

Huashi Jiangzhuo is a Traditional Chinese Medicine (TCM) herbal decoction developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is specifically formulated for the treatment of newly diagnosed type 2 diabetes mellitus (T2DM), targeting patients who present with 'damp-heat syndrome' according to TCM diagnostic criteria. The prescription is designed to clear heat and resolve dampness, addressing the underlying pathological factors believed to contribute to metabolic dysfunction in this patient population. It is currently being evaluated in multi-center randomized controlled clinical studies to provide evidence-based support for the efficacy and safety of TCM interventions in the management of diabetes.

Other names: Huashi Jiangzhuo prescriptionHuashi Jiangzhuo Decoction

Beyond the preview

Go deeper on Huashi Jiangzhuo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huashi Jiangzhuo.

Explore the full profile